Ultimately, it was recently showed that CRC patients displayed high levels of HMGA1 protein in the blood, compared to healthy individuals, thus revealing a potential use of HMGA1 expression levels as a noninvasive CRC diagnostic biomarker [71]. This evidence concerns the gene HMGA1 and colorectal carcinoma.